Literature DB >> 9793030

Production of granulocyte-macrophage colony-stimulating factor in a patient with metastatic chest wall large cell carcinoma.

M Watanabe1, K Ono, Y Ozeki, S Tanaka, S Aida, Y Okuno.   

Abstract

Recent reports of cancers that produce colony-stimulating factors (CSF) and which are associated with leukocytosis indicate that most are granulocyte CSF-producing tumors. A 71-year-old man with metastatic chest wall tumors from large cell lung cancer with marked leukocytosis and eosinophilia was reported. His maximal leukocyte count was 48300/microliter with 37.5% eosinophils. Granulocyte-macrophage CSF (GM-CSF) activity detected by enzyme-linked immunosorbent assay (ELISA) in serum was 112 pg/ml (normal range < 2.0 pg/ml), but G-CSF was normal. Immunohistochemical detection of GM-CSF protein on a chest wall tumor sample was positive. Irradiation of the chest wall tumor was performed and the leukocyte count decreased temporally. However, he died of respiratory failure due to progressive tumor growth 56 days after admission. Based on these results it appears that autocrine production of GM-CSF is a possible cause of this leukemoid reaction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9793030     DOI: 10.1093/jjco/28.9.559

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  15 in total

1.  Pulmonary pleomorphic carcinoma producing granulocyte-macrophage colony-stimulating factor: report of a case.

Authors:  Toshinori Fukutomi; Mitsutomo Kohno; Yotaro Izumi; Masazumi Watanabe; Yuichiro Hayashi; Hiroaki Nomori
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

2.  Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factor.

Authors:  Y-H Cui; Y Suh; H-J Lee; K-C Yoo; N Uddin; Y-J Jeong; J-S Lee; S-G Hwang; S-Y Nam; M-J Kim; S-J Lee
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

Review 3.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

4.  Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

Authors:  Tilman Todenhöfer; Stefan Wirths; Claus Hann von Weyhern; Stefan Heckl; Marius Horger; Joerg Hennenlotter; Arnulf Stenzl; Lothar Kanz; Christian Schwentner
Journal:  BMC Urol       Date:  2012-03-21       Impact factor: 2.264

5.  Leukemoid like reaction in a post CABG patient.

Authors:  G Padmakumar; J Ravikrishnan; P Jayakumar; K Prasad
Journal:  Indian J Anaesth       Date:  2014-05

6.  A Case of Ovarian Clear Cell Carcinoma Simultaneously Producing Parathyroid Hormone-related Protein and Granulocyte Colony-Stimulating Factor.

Authors:  Masayuki Futagami; Yoshihito Yokoyama; Moe Wakui; Ryousuke Taniguchi; Tsuyoshi Higuchi; Hideki Mizunuma
Journal:  World J Oncol       Date:  2010-05-19

7.  Rapidly evolving asymptomatic eosinophilia in a patient with lung adenocarcinoma causes cognitive disturbance and respiratory insufficiency: Case report.

Authors:  Cheng-Hsiang Lo; Yee-Min Jen; Wen-Chiuan Tsai; Ping-Ying Chung; Woei-Yau Kao
Journal:  Oncol Lett       Date:  2012-11-09       Impact factor: 2.967

Review 8.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.834

9.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.530

10.  Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factor.

Authors:  Ryoji Harada; Yoshiki Uemura; Makoto Kobayashi; Adriana Zamecnikova; Hideshi Nakata; Takahiro Taguchi; Mutsuo Furihata; Yuji Otsuki; Hirokuni Taguchi
Journal:  Jpn J Cancer Res       Date:  2002-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.